Paula Vieira‐Martins

Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy

Amy J. Osborne, Matteo Breno, Nicolò Ghiringhelli Borsa et al. · The Journal of Immunology · 2018 · 168 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

Régis Peffault de Latour, Véronique Frémeaux‐Bacchi, Raphaël Porcher et al. · Blood · 2014 · 167 citations · Full text

Medicine, Hematology, Pharmacology +12

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

Elizabeth C. Schramm, Lubka T. Roumenina, Tania Rybkine et al. · Blood · 2015 · 138 citations · Full text

Life Sciences, Genetics, Immunology +14

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors

Alice Le Clech, Noémie Simon‐Tillaux, François Provôt et al. · Kidney International · 2019 · 117 citations · Full text

Medicine, Hematology, Nephrology +11

Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy

Lubka T. Roumenina, Philippe Chadebech, Gwellaouen Bodivit et al. · American Journal of Hematology · 2020 · 68 citations · Full text

Life Sciences, Hematology, Immunology +17